304 related articles for article (PubMed ID: 29444487)
1. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
[TBL] [Abstract][Full Text] [Related]
3. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
4. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
5. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
Wu X; Jin C; Wang F; Yu C; McKeehan WL
Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
[TBL] [Abstract][Full Text] [Related]
7. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
[TBL] [Abstract][Full Text] [Related]
9. FGF signaling in prostate tumorigenesis--new insights into epithelial-stromal interactions.
Abate-Shen C; Shen MM
Cancer Cell; 2007 Dec; 12(6):495-7. PubMed ID: 18068626
[TBL] [Abstract][Full Text] [Related]
10. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.
Memarzadeh S; Xin L; Mulholland DJ; Mansukhani A; Wu H; Teitell MA; Witte ON
Cancer Cell; 2007 Dec; 12(6):572-85. PubMed ID: 18068633
[TBL] [Abstract][Full Text] [Related]
11. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Olson DC; Hanahan D
Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
[TBL] [Abstract][Full Text] [Related]
14. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
Curto M; Frankel P; Carrero A; Foster DA
Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
[TBL] [Abstract][Full Text] [Related]
15. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
[TBL] [Abstract][Full Text] [Related]
16. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis.
Josson S; Gururajan M; Sung SY; Hu P; Shao C; Zhau HE; Liu C; Lichterman J; Duan P; Li Q; Rogatko A; Posadas EM; Haga CL; Chung LW
Oncogene; 2015 May; 34(21):2690-9. PubMed ID: 25065597
[TBL] [Abstract][Full Text] [Related]
17. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
19. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
Jin C; McKeehan K; Guo W; Jauma S; Ittmann MM; Foster B; Greenberg NM; McKeehan WL; Wang F
Cancer Res; 2003 Dec; 63(24):8784-90. PubMed ID: 14695195
[TBL] [Abstract][Full Text] [Related]
20. Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.
Franco OE; Jiang M; Strand DW; Peacock J; Fernandez S; Jackson RS; Revelo MP; Bhowmick NA; Hayward SW
Cancer Res; 2011 Feb; 71(4):1272-81. PubMed ID: 21303979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
